const e=JSON.parse(`[{"number":1,"question":"Which of the following core symptoms of autism has demonstrated minimal success in treatment with risperidone?","options":{"A":"Aggressive behavior","B":"Repetitive and stereotyped patterns of behavior","C":"Deficits in social interaction and communication","D":"Self-injurious behavior","E":"Hallucinations"},"correct_answer":"C","explanation":"Risperidone has modest benefits in improving deficits in social interaction and communication, despite being effective for aggression and other symptoms."},{"number":3,"question":"All of the following medications have a role in the treatment of tics EXCEPT:","options":{"A":"Haloperidol","B":"Pimozide","C":"Atomoxetine","D":"Clonidine","E":"Tetrabenazine"},"correct_answer":"C","explanation":"Atomoxetine does not have a role in the management of tics and is reported to exacerbate tics in children with ADHD."},{"number":4,"question":"Which of the following interventions has the highest priority for a 16-year-old boy being treated for schizophrenia, showing withdrawal and lack of interest?","options":{"A":"Monitor for metabolic side effects of paliperidone by obtaining fasting lipid profile","B":"Conduct an Abnormal Involuntary Movement Scale test (AIMS) exam","C":"Assess for symptoms of major depression and consider antidepressant treatment","D":"Family and individual counseling about schizophrenia","E":"Assessment of social and educational needs of the patient"},"correct_answer":"C","explanation":"Adolescent schizophrenia is often accompanied by negative symptoms and depressive symptoms; assessing for depression and considering treatment is critical."},{"number":5,"question":"Which of the following is used as a first-line agent in the treatment of enuresis?","options":{"A":"Venlafaxine","B":"Fluoxetine","C":"Imipramine","D":"Desmopressin","E":"Modafinil"},"correct_answer":"D","explanation":"Desmopressin is the first-line treatment for primary nocturnal enuresis."},{"number":6,"question":"All of the following statements are true except regarding the use of clonidine in children EXCEPT:","options":{"A":"Clonidine is useful in the pharmacologic treatment of Tourette syndrome in children","B":"Sedation is the most frequent and troublesome side effect of clonidine","C":"Personal history of cardiovascular disease is contraindication for starting clonidine therapy in children","D":"Clonidine should be titrated gradually, and dose can be increased every 2 to 3 days","E":"Clonidine has a long half-life, and it is administered orally once or twice a day"},"correct_answer":"E","explanation":"Clonidine has a very short half-life and is typically administered three to four times daily instead."},{"number":7,"question":"What is the most appropriate next step in the management of a 14-year-old female with depression who has not responded to two SSRIs?","options":{"A":"Reassess diagnosis; especially rule out bipolar disorder or comorbid ADHD","B":"Consider augmentation with lithium","C":"Consider augmentation with venlafaxine","D":"Consider augmentation with atypical antipsychotics","E":"All of the above"},"correct_answer":"A","explanation":"It is important to reevaluate and confirm the diagnosis and rule out comorbid conditions like bipolar disorder or ADHD before considering augmentation."},{"number":8,"question":"You are treating a 15-year-old adolescent boy for ADHD and comorbid depression. Which management will be the most appropriate next step?","options":{"A":"Start bupropion for depression and ADHD","B":"Attempt a trial of fluoxetine","C":"Prescribe a combination of fluoxetine and a stimulant such as methylphenidate","D":"Prescribe atomoxetine","E":"Start with methylphenidate monotherapy"},"correct_answer":"B","explanation":"In addressing the bigger problem of depression, attempting a trial of fluoxetine would target both sets of symptoms."},{"number":9,"question":"All of the following statements regarding psychostimulant growth slowdown are true EXCEPT:","options":{"A":"Stimulant-induced appetite suppression and reduced caloric intake may play a role in growth retardation","B":"Stimulants may suppress growth hormone release","C":"Height and weight gain should be recorded once a year in patients receiving stimulants","D":"In the presence of height or weight velocity, dose reduction has no role and change to another class of medication must be carried out","E":"None of the above"},"correct_answer":"C","explanation":"Height and weight should be monitored periodically for growth suppression, not just once a year."},{"number":10,"question":"Which of the following statements is true regarding the differences in drug metabolism between children and adults?","options":{"A":"Children have proportionally smaller liver tissue","B":"Children have slower hepatic drug metabolism","C":"Children have lower glomerular filtration rates","D":"Children may more rapidly excrete the drug that uses either hepatic or renal pathways","E":"All of the above"},"correct_answer":"D","explanation":"Children have proportionally more liver tissue, leading to faster metabolism, and they also have higher glomerular filtration rates."},{"number":11,"question":"Which of the following statement is true regarding the pharmacologic treatment of ADHD symptoms among children and adolescents with intellectual disability?","options":{"A":"Risperidone should be the first line of treatment","B":"Stimulants should be the first line of treatment","C":"Combination of antipsychotic and stimulant is the standard of care","D":"Antidepressants should be the first line of treatment","E":"Anticonvulsants should be the first line of treatment"},"correct_answer":"B","explanation":"Stimulants like methylphenidate are first-line treatments for ADHD symptoms in children with intellectual disabilities."},{"number":12,"question":"Which of the following statement is true regarding the pharmacotherapy of ADHD?","options":{"A":"Methylphenidate is approved for children >2 to 3 years","B":"Methylphenidate is approved for children >4 years","C":"Methylphenidate is approved for children >5 years","D":"Methylphenidate is approved for children >6 years","E":"Methylphenidate is approved for children >7 years"},"correct_answer":"D","explanation":"Methylphenidate is only approved for children older than 6 years, due to a lack of established safety and efficacy for younger patients."},{"number":13,"question":"Which of the following statement is true regarding the pharmacotherapy of ADHD with amphetamine?","options":{"A":"Amphetamine is approved for children >3 years","B":"Amphetamine is approved for children >6 years","C":"Amphetamine can be safely used in a patient with hyperthyroidism","D":"Amphetamine can be safely used within a week following discontinuation of monoamine oxidase inhibitors (MAOIs)","E":"Amphetamine can be safely used in children with structural cardiac abnormalities"},"correct_answer":"A","explanation":"Amphetamine is approved for children older than 3 years; its safety and efficacy have not been established for younger patients."},{"number":14,"question":"Among children, which of the following medications affects cardiovascular functioning and may prolong QTc even at therapeutic doses?","options":{"A":"Clonidine","B":"Thioridazine","C":"Tricyclic antidepressants","D":"Lithium","E":"All of the above"},"correct_answer":"E","explanation":"First-generation and second-generation antipsychotics, tricyclic antidepressants, and lithium can all affect cardiovascular functioning."},{"number":15,"question":"Which of the following is the most common side effect with intranasal Desmopressin?","options":{"A":"Water intoxication","B":"Headache","C":"Epistaxis","D":"Abdominal pain","E":"Seizure"},"correct_answer":"B","explanation":"Headache is the most common side effect reported during the use of intranasal desmopressin."},{"number":16,"question":"Which of the following medications is FDA approved for major depressive disorder (MDD) in adolescents?","options":{"A":"Citalopram","B":"Sertraline","C":"Escitalopram","D":"Paroxetine","E":"Fluvoxamine"},"correct_answer":"C","explanation":"Escitalopram and fluoxetine are currently approved by the FDA for the treatment of pediatric depression."},{"number":17,"question":"Which of the following statements is true regarding the pharmacokinetics in children?","options":{"A":"Children have proportionally less total-body water than adults","B":"Children have higher plasma concentrations of hydrophilic drugs than adults","C":"Children have proportionally less adipose tissue than adults","D":"Children have lower plasma concentrations of lipophilic drugs","E":"All of the above"},"correct_answer":"C","explanation":"Children have proportionally less adipose tissue than adults, but their total body water is higher, influencing drug pharmacokinetics."},{"number":18,"question":"B-adrenergic agents are used in the management of aggression associated with which of the following conditions?","options":{"A":"Intermittent explosive disorder","B":"Traumatic brain injury","C":"Autism","D":"ADHD","E":"All of the above"},"correct_answer":"E","explanation":"Î²-Adrenergic agents are employed in managing aggression related to various conditions, including those mentioned."},{"number":19,"question":"Which of the following statements is not true regarding psychopharmacotherapy between children and adults?","options":{"A":"Psychopharmacotherapy in children is distinct from adults","B":"Metabolism of drugs differs between children and adults","C":"Efficacy and tolerability of psychotropic drugs differs between children and adults","D":"Abundant research data on pediatric psychopharmacology is available","E":"Treatment in child psychiatry is mostly multidisciplinary in nature"},"correct_answer":"D","explanation":"There is actually little data available on pediatric psychopharmacology compared to adult studies."},{"number":20,"question":"All of the following statements regarding dexmethylphenidate (Focalin) are true EXCEPT:","options":{"A":"Dexmethylphenidate is the active D-enantiomer of racemic methylphenidate","B":"For patients currently on methylphenidate, the recommended starting dose of dexmethylphenidate is half the total daily dose of racemic methylphenidate","C":"Dexmethylphenidate can be administered by sprinkling the capsule contents on a small amount of applesauce","D":"The difference in duration of action between dexmethylphenidate and methylphenidate is not clinically significant","E":"Studies indicate a more favorable adverse effect profile for dexmethylphenidate compared to methylphenidate"},"correct_answer":"E","explanation":"Studies have not shown a more favorable adverse effect profile for dexmethylphenidate compared to methylphenidate."},{"number":21,"question":"All of the following statements regarding lisdexamfetamine are true EXCEPT:","options":{"A":"It is a prodrug of dextroamphetamine","B":"Lisdexamfetamine is not metabolized by cytochrome P450 enzymes","C":"Lisdexamfetamine dimesylate has lower abuse potential","D":"The drug's short duration of action is a key determinant of its efficacy in school-going children with ADHD","E":"It is a schedule II drug which means that automated refills are not allowed"},"correct_answer":"D","explanation":"Lisdexamfetamine actually has a long-acting duration of effect which is important for its efficacy in school-aged children."},{"number":22,"question":"Which of the following must be closely monitored during guanfacine therapy?","options":{"A":"Liver function test","B":"Renal function test","C":"Blood pressure","D":"Lipid panel","E":"Platelet count"},"correct_answer":"C","explanation":"Guanfacine therapy is associated with decreased blood pressure, thus requiring periodic monitoring."},{"number":23,"question":"Which of the following can be a potential risk factor for increased blood pressure and seizure in children taking Atomoxetine?","options":{"A":"Co-administration of Aripiprazole","B":"Co-administration of Risperidone","C":"Co-administration of bupropion","D":"Slow CPY2D6 metabolizer","E":"All of the above"},"correct_answer":"D","explanation":"Poor metabolizers can see a significant increase in atomoxetine levels, raising the risk of high blood pressure and seizures."},{"number":24,"question":"Which of the following medications has the strongest evidence for the management of aggression and self-injurious behavior in children with autism spectrum disorders?","options":{"A":"Methylphenidate","B":"Naltrexone","C":"Clonidine","D":"Lithium","E":"Fluoxetine"},"correct_answer":"A","explanation":"Methylphenidate has strong evidence supporting its use in managing aggression and self-injurious behavior in autism."},{"number":25,"question":"Which of the following statements is true regarding cardiovascular assessment and monitoring during pediatric ADHD pharmacotherapy?","options":{"A":"The American Heart Association requires a mandatory electrocardiogram (EKG) before starting stimulants in ADHD","B":"Clinical studies have demonstrated statistically significant changes in QTc parameters during pediatric ADHD pharmacotherapy with stimulants as well as non-stimulants","C":"The link between stimulants and sudden death in children is well established","D":"There is an FDA black box warning regarding cardiovascular fatalities associated with the use of stimulants in ADHD","E":"None of the above"},"correct_answer":"E","explanation":"No definitive causality has been established between serious cardiovascular events and stimulant use."},{"number":26,"question":"Which of the following is true regarding Alpha-adrenergic agonist therapy in children?","options":{"A":"Clonidine is used in the management of ADHD","B":"Clonidine is used in the management of tics","C":"Guanfacine is used in the management of Gilles de la Tourette syndrome","D":"Guanfacine is FDA-approved treatment for ADHD","E":"All of the above"},"correct_answer":"E","explanation":"Each option reflects correct uses of alpha-adrenergic agonists in managing the mentioned conditions."},{"number":27,"question":"Which of the following mood stabilizers have been associated with the development of polycystic ovarian syndrome (PCOS)?","options":{"A":"Lithium","B":"Valproic acid","C":"Aripiprazole","D":"Ziprasidone","E":"None of the above"},"correct_answer":"B","explanation":"Valproic acid has been associated with the development of PCOS, especially in young women."},{"number":28,"question":"Which of the following is proven to be efficacious in the treatment of Tourette disorder?","options":{"A":"Methylphenidate","B":"Pimozide","C":"Clonazepam","D":"Propranolol","E":"Atomoxetine"},"correct_answer":"B","explanation":"Pimozide is FDA-approved for the treatment of Gilles de la Tourette syndrome."},{"number":29,"question":"What is the next best step in the management of a 10-year-old girl with ADHD and a family history of long QT syndrome who is being considered for stimulant therapy?","options":{"A":"Order an electrocardiogram","B":"Order an echocardiogram","C":"Request a 24-hour Holter monitoring","D":"Consult a pediatric cardiologist","E":"Start bupropion instead of a stimulant"},"correct_answer":"A","explanation":"In cases of risk factors for cardiac disease, including family history, it is essential to perform an ECG before starting stimulant therapy."},{"number":30,"question":"All of the following are true regarding methylphenidate EXCEPT:","options":{"A":"The drug inhibits reuptake of dopamine and norepinephrine into presynaptic neurons","B":"It is inconclusive whether or not prolonged use of methylphenidate can significantly limit height and body weight","C":"Dexmethylphenidate (Focalin) is the D-enantiomer of methylphenidate","D":"The efficacy and safety of methylphenidate has not been established in patients <6 years of age","E":"Routine baseline EKGs are recommended before starting methylphenidate therapy"},"correct_answer":"E","explanation":"Routine EKGs are indicated only in cases of personal or family history of cardiac conditions, not as a baseline for all patients."},{"number":31,"question":"All of the following statements regarding methylphenidate transdermal system are true EXCEPT:","options":{"A":"The patch should be applied to the hip area and should be removed 6 hours after application","B":"The effect on average dissipates 3 hours after patch removal","C":"The transdermal formulation produces higher exposures of dexmethylphenidate compared with oral administration","D":"It is dosed once a day","E":"None of the above"},"correct_answer":"A","explanation":"The transdermal patch must be applied 2 hours before the needed effect and should only be removed 9 hours after application."},{"number":32,"question":"Which of the following is the first-line pharmacotherapy for childhood anxiety disorder?","options":{"A":"Sertraline","B":"Lorazepam","C":"Imipramine","D":"Modafinil","E":"Venlafaxine"},"correct_answer":"A","explanation":"SSRIs like sertraline are established as the first-line treatment for childhood anxiety disorders."},{"number":33,"question":"All of the following statements regarding Atomoxetine are true EXCEPT:","options":{"A":"FDA approved for ADHD","B":"Middle insomnia is characteristic of noradrenergic rebound and might be expected during Atomoxetine therapy","C":"Atomoxetine has no effect on blood pressure and pulse when compared with stimulants","D":"Atomoxetine has no abuse liability","E":"Atomoxetine has a black box warning for suicidal ideation in children and adolescents"},"correct_answer":"C","explanation":"Atomoxetine is reported to increase systolic and diastolic blood pressure, in contrast to what option C states."},{"number":34,"question":"Which of the following statement is true regarding neuroleptic-induced extrapyramidal side effects among children and adolescents?","options":{"A":"Risk of extrapyramidal symptoms (EPS) increases with higher doses of Aripiprazole","B":"Quetiapine is associated with lower EPS","C":"Children and adolescents are more sensitive than adults to EPS associated with atypical antipsychotics","D":"Children and adolescents are more sensitive than adults to EPS associated with typical antipsychotics","E":"All of the above"},"correct_answer":"E","explanation":"Each statement regarding the increased risk of EPS with higher doses and sensitivity differences between children and adults is true."},{"number":35,"question":"Which of the following is true regarding the management of insomnia in pediatric patients?","options":{"A":"Zaleplon because of its shorter half-life is the preferred agent","B":"There is no FDA-approved agent for the management of insomnia","C":"Nonpharmacologic therapy combined with pharmacotherapy yields the optimal response","D":"Cognitive behavioral therapy has very limited role in the management of insomnia","E":"All of the above"},"correct_answer":"B","explanation":"Currently, there is no FDA-approved medication for treating insomnia in children; nonpharmacologic therapies are preferred."},{"number":36,"question":"All of the following SSRIs are FDA approved treatment for obsessive compulsive disorder (OCD) EXCEPT:","options":{"A":"Fluoxetine","B":"Fluvoxamine","C":"Sertraline","D":"Citalopram","E":"None of the above"},"correct_answer":"D","explanation":"All options except for option D are SSRIs that have been FDA approved for the treatment of OCD."},{"number":37,"question":"Which of the following treatment is associated with better outcome in primary nocturnal enuresis?","options":{"A":"Imipramine","B":"Desmopressin","C":"Modafinil","D":"Bell and pad conditioning","E":"All of the above"},"correct_answer":"D","explanation":"Bell and pad conditioning has shown better outcomes in preventing relapse of enuresis after treatment compared to medications."}]`);export{e as default};
